These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 22542764

  • 1. Role of intravenous cloxacillin for inpatient infections.
    Bru JP, Garraffo R.
    Med Mal Infect; 2012 Jun; 42(6):241-6. PubMed ID: 22542764
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Is methicillin better than cloxacillin in serious infections caused by strong penicillinase-producing staphylococci (phage-type 94/96)?].
    Siboni AH, Jensen KT, Rosdahl VT, Gaub J.
    Ugeskr Laeger; 1995 Mar 27; 157(13):1862-4. PubMed ID: 7725565
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Resistance pattern of antibiotics against clinical isolates of Staphylococcus aureus.
    Sattar SA, Farzana K, Hameed A.
    Pak J Pharm Sci; 2005 Oct 27; 18(4):18-22. PubMed ID: 16380353
    [Abstract] [Full Text] [Related]

  • 12. [Susceptibility of 609 strains of Staphylococcus aureus, isolated during 1973-1974 from various infectious processes in children, to various antibiotics].
    Filloy L, Borjas García E, Vitela AE.
    Bol Med Hosp Infant Mex; 1976 Oct 27; 33(2):473-9. PubMed ID: 1259824
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates.
    Socha AM, LaPlante KL, Rowley DC.
    Bioorg Med Chem; 2006 Dec 15; 14(24):8446-54. PubMed ID: 16979896
    [Abstract] [Full Text] [Related]

  • 16. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A.
    Arch Intern Med; 2006 Oct 23; 166(19):2138-44. PubMed ID: 17060545
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of tolerance in cloxacillin prophylaxis of experimental Staphylococcus aureus endocarditis.
    Voorn GP, Thompson J, Goessens WH, Schmall-Bauer W, Broeders PH, Michel MF.
    J Infect Dis; 1992 Jul 23; 166(1):169-73. PubMed ID: 1607692
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial.
    Burdet C, Loubet P, Le Moing V, Vindrios W, Esposito-Farèse M, Linard M, Ferry T, Massias L, Tattevin P, Wolff M, Vandenesch F, Grall N, Quintin C, Mentré F, Duval X, Lescure FX, CloCeBa study group.
    BMJ Open; 2018 Sep 01; 8(8):e023151. PubMed ID: 30173161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.